Neuren Pharmaceuticals LimitedASX: NEU

FDA approves Daybue - the first treatment for Rett syndrome

Mar 13, 2023 at 2:30 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment